P2RY12 and Sepsis: Antiplatelet agents have also been identified as potential therapeutics impacting sepsis treatment, because clinical data have shown a correlation between the use of aspirin and P2Y12 inhibitors and lower mortality in patients with systemic inflammatory response syndrome and sepsis.57, 58, 59, 60